SCHEMBL24649915

SCHEMBL24649915

COC(=O)c1ccc(N2CCN(C(=O)OC(C)(C)C)[C@@H](C)C2)cn1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 3/20 0.49
▸ HDAC1 Q13547 1/20 0.49
▸ MAP4K4 O95819 1/20 0.49
▸ NR1H2 P55055 7/20 0.46
▸ NR1H3 Q13133 6/20 0.46
▸ HRH3 Q9Y5N1 2/20 0.46
▸ SUV39H2 Q9H5I1 2/20 0.45
▸ MEN1 O00255 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ AR P10275 1/20 0.42
▸ FAAH O00519 1/20 0.40
▸ MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25738205 1.00 GPR119 (0.49) GPR119HDAC1MAP4K4NR1H2NR1H3
SCHEMBL24649853 1.00 GPR119 (0.49) GPR119HDAC1MAP4K4NR1H2NR1H3
SCHEMBL16339346 0.89 GPR119 (0.51) GPR119HDAC1MAP4K4NR1H2NR1H3
SCHEMBL24649851 0.88 HDAC1 (0.51) GPR119HDAC1MAP4K4NR1H2NR1H3
SCHEMBL24649916 0.88 HDAC1 (0.51) GPR119HDAC1MAP4K4NR1H2NR1H3
SCHEMBL25916778 0.88 HDAC1 (0.51) GPR119HDAC1MAP4K4NR1H2NR1H3
SCHEMBL25738206 0.88 MAP4K4 (0.52) GPR119HDAC1MAP4K4NR1H2NR1H3
SCHEMBL25738081 0.87 NR1H2 (0.58) GPR119HDAC1NR1H2NR1H3HRH3
SCHEMBL25738094 0.86 NR1H2 (0.47) GPR119HDAC1NR1H2NR1H3HRH3
SCHEMBL12306721 0.86 GPR119 (0.46) GPR119HDAC1NR1H2NR1H3HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023109521-A1 PARP INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF 凯复(苏州)生物医药有限公司 2023-06-22 — — WO disclosed
WO-2022222995-A1 PICOLINAMIDE COMPOUND 南京明德新药研发有限公司 2022-10-27 — — WO disclosed
Send feedback